iridex.com (IRIX) - Koefisien utang jangka dawa marang modal

The ratio of long-term loans to equity at IRIDEX Corporation (IRIX) demonstrates financial stability, where 0.99 represents the latest level. The company is optimizing its optics supply chains to ensure stable shipments of laser systems. Its leadership in ophthalmology is solidified by the safe MicroPulse technology. Simultaneously, the R&D center is conducting a systematic modernization of equipment, creating innovative devices for the treatment of the retina and glaucoma.

This indicator assesses financial stability through the ratio of long-term liabilities to equity. By analyzing the long-term debt-to-equity ratio, an investor determines the company's degree of dependence on external borrowing. The calculation is based on dividing loans with a maturity of over one year by net assets, which allows for an assessment of the risk of growth stagnation. For IRIDEX Corporation (IRIX), such a liability structure is critical when scaling the supply of ophthalmological equipment.